AT

Abhishek Tyagi

Active Director Director DIN 11537142
DIN 11537142 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Abhishek Tyagi

Data last updated:

Abhishek Tyagi is a Director at R&T Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11537142
Primary Designation Director
Industry Pharma
First Appointment 10 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
R&T Pharmaceuticals Private Limited U21001UP2026PTC243764
Director10 Feb 20262026Active

Board colleagues of Abhishek Tyagi

NameDINCompanyDesignation
Rahul Chauhan11537143R&T Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
R&T Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Abhishek Tyagi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Tyagi

Abhishek Tyagi currently holds 1 directorship: R&T Pharmaceuticals Private Limited (Director, since 10 Feb 2026).

Abhishek Tyagi was first appointed on 10 Feb 2026 as Director at R&T Pharmaceuticals Private Limited.

The current boards of Abhishek Tyagi's companies include Rahul Chauhan (R&T Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available